ID   NZM095
AC   CVCL_0D55
SY   NZM95
DR   Wikidata; Q54931638
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J.,
RA   Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S.,
RA   Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.;
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//